FRANKIE MCCURRY: Open Payments
NPI 1710577176 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 44 payments from 15 companies in 2025. Trend: 2023 $658 · 2024 $2,525 · 2025 $1,131
Food & beverage: $957Education: $175
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $202 |
| GENZYME CORPORATION | 10 | $202 |
| ABBVIE INC. | 8 | $141 |
| UCB, Inc. | 2 | $140 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Janssen Biotech, Inc. | 2 | $91 |
| Almirall LLC | 2 | $57 |
| Galderma Laboratories, L.P. | 3 | $52 |
| Organon LLC | 3 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, Seysara, NEMLUVIO, VTAMA, INTERSTIM.
Industry payments across GA — which companies pay providers there.
